Institutional Profile

Since 1944, more than 1.9 million people have turned to MD Anderson for cancer care. 

MD Anderson pathologists refine a new patient's initial diagnosis by another institution up to 25% of the time.

MD Anderson's world-renowned physicians are extensively trained specialists who focus on one type of cancer and one aspect of treatment, giving them unrivaled expertise. 100% of MD Anderson's surgeons are trained in oncology compared to 30% in community hospitals. 

MD Anderson provided uninsured or underinsured Texans more than $309 million in uncompensated care in FY22.

At MD Anderson, important scientific knowledge gained in the laboratory is rapidly translated to clinical care. 

MD Anderson is home to one of the world's largest cancer clinical trials programs, providing patients with access to life-saving investigational drugs before they are approved by the Food and Drug Administration (FDA). 

MD Anderson receives millions of dollars in grant funding from the Cancer Prevention Research Institute of Texas (CPRIT) for research, prevention, recruitment and training. MD Anderson received more than $32 million in funding from CPRIT in FY22.

MD Anderson holds nine National Cancer Institute Specialized Programs of Research Excellence (SPORE) grants in endometrial, prostate, melanoma, gastrointestinal, brain, leukemia, lung, ovarian and hepatocellular cancers.